期刊文献+

养心氏片联合左甲状腺素钠治疗甲状腺功能减退性心脏病疗效分析 被引量:15

Therapeutic Effect Analysisi of Yangxin Tablet Combined with Levothyroxine Sodium in Treatment of Hypothyroid Heart Disease
下载PDF
导出
摘要 目的:观察养心氏片联合左甲状腺素钠治疗甲状腺功能减退性心脏病疗效分析。方法:治疗组150例养心氏片联合左甲状腺素钠治疗;对照组100例单纯左甲状腺素钠治疗。结果:治疗组总有效率97.37%,明显优于对照组75.76%(P<0.05)。2组治疗后T3、T4、FT3、FT4、TSH、LVEF、ATIII、FIB、TM较本组治疗前均有改善(P<0.05);且治疗组治疗后T3、T4、FT3、FT4、TSH、LVEF、ATIII、FIB、TM均优于对照组治疗后(P<0.05)。结论:养心氏片联合优甲乐治疗甲状腺功能减退性心脏病疗效显著、改善症状快速,且无明显不良反应。 Abstract Objective: To observe curative effect analysis Yangxin Tablet combined with levothyroxine sodium in treatment of hypo- thyroid heart disease. Methods:The treatment group included 150 cases, given the treatment of yangxin tablet combined with levo- thyroxine sodium, while patients in the control group with 100 cases were only given levothyroxine sodium treatment. Results :The total effectiveness of the treatment group was 97.37% and was obviously better than that of the control group (75.76%) with sta- tistical significant difference (P 〈 0. 05 ). T3, T4, FT3, FT4, TSH, LVEF, ATIII, FIB, and TM of both the two groups after treatment were improved, compared with those before treatment ( P 〈 0. 05 ) and those of the treatment group were superior to those of the control group ( P 〈 0. 05 ). Conclusion: The curative effect of Yangxin Tablet combined with levothyroxine sodium in treat- ment of hypothyroid heart disease is distinct, with fast symptoms improvement and no obvious side effects.
出处 《世界中医药》 CAS 2016年第5期810-812,共3页 World Chinese Medicine
基金 广西卫生厅自筹经费科研课题--左甲状腺素钠替代治疗甲状腺功能减退症对血管内皮功能影响的临床研究(编号:z2014019)
关键词 养心氏片 左甲状腺素钠 甲状腺功能减退性心脏病 Yangxin Tablet Levothyroxine sodium Hypothyroid heart disease
  • 相关文献

参考文献13

  • 1耿德章.中国老年病学[M].北京:人民卫生出版社,2002.371.
  • 2王晶荣,张志利.关于亚临床甲减治疗的研究现状[J].中国实用医药,2010,5(7):251-252. 被引量:15
  • 3涂燕平,雷梦觉,吴小和,龚爱斌,魏伟荣,王凌玲,艾文伟,邬甦,姚晓璐.亚临床甲状腺功能减退与冠心病患者血管内皮功能与炎症反应之间关系的研究[J].临床荟萃,2011,26(6):491-493. 被引量:18
  • 4袁庆新,刘超.甲状腺激素对心血管系统影响的新认识[J].国外医学(内科学分册),2004,31(8):327-330. 被引量:32
  • 5CaPPolaAR, LadensonPW. HyPothyroidismandatheroselerosis [J]. J Clin Endoerinol Metab,2003,88(6) :2438-2444.
  • 6MayerOJr, Simon J, FiliPovskyJ, et al. HyPothyroidismin coro2 nary- heartdiseaseanditsrelationtoselectedriskfactors [J]. Vasc HealthRisk- Manag, 2006,2 ( 4 ) :499 -506.
  • 7Asvold BO, VattenLJ, NilsenT1, et al. Theassociation between TSH withinthereference RangeandserumliPid concentrationsinaPoPulalion- basedstudy. Thehuntstudy[J]. Eur J Endocrinol,2007,156 ( 2 ) : 181 - 186.
  • 8Ashizawa K, lmaizumi M, Usa T, et al. Metabolic cardiovasculardis- ease risk factors and their clustering in subclinical hypothyroidism [J]. Clin Endocrinol(Oxf) ,2010,72(5 ) :689.
  • 9Conway EM. Thrombomodulin and its role ininflammation [J]. Semi- nImmunopathol, 2012,34 ( 1 ) : 107 -25.
  • 10Carnemolla R, Patel KR, Zaitsev S, et al. Quantitative analysis of- thrombomodulin-mediated conversion of protein C to APC : transla- tionfrom in vitro to in vivo [J].Immunol Methods, 2012,384 ( 1- 2) :21-4.

二级参考文献67

共引文献335

同被引文献213

引证文献15

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部